mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
The vaccine reportedly thwarted the cancer's return and spread.
What happened?
The vaccine reportedly thwarted the cancer's return and spread.
Story details
The vaccine reportedly thwarted the cancer's return and spread.
Why it matters
This story helps build a stronger internal English tech archive around Technology, giving search visitors more reasons to keep browsing the site instead of bouncing after a single headline.